155 related articles for article (PubMed ID: 19360752)
1. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
Shrivastav A; Varma S; Senger A; Khandelwal RL; Carlsen S; Sharma RK
J Pathol; 2009 Jul; 218(3):391-8. PubMed ID: 19360752
[TBL] [Abstract][Full Text] [Related]
2. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
3. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity.
Varma S; Shrivastav A; Changela S; Khandelwal RL
Exp Cell Res; 2008 Apr; 314(6):1281-91. PubMed ID: 18261725
[TBL] [Abstract][Full Text] [Related]
5. Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation.
Qiao M; Iglehart JD; Pardee AB
Cancer Res; 2007 Jun; 67(11):5293-9. PubMed ID: 17545609
[TBL] [Abstract][Full Text] [Related]
6. The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells.
Wollmann W; Goodman ML; Bhat-Nakshatri P; Kishimoto H; Goulet RJ; Mehrotra S; Morimiya A; Badve S; Nakshatri H
Carcinogenesis; 2005 May; 26(5):900-7. PubMed ID: 15677629
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.
Smith MJ; Culhane AC; Killeen S; Kelly MA; Wang JH; Cotter TG; Redmond HP
Ann Surg Oncol; 2008 Oct; 15(10):2954-64. PubMed ID: 18622646
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.
Al-Bazz YO; Underwood JC; Brown BL; Dobson PR
Eur J Cancer; 2009 Mar; 45(4):694-704. PubMed ID: 19138840
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.
Dandachi N; Hauser-Kronberger C; Moré E; Wiesener B; Hacker GW; Dietze O; Wirl G
J Pathol; 2001 Feb; 193(2):181-9. PubMed ID: 11180164
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
[TBL] [Abstract][Full Text] [Related]
12. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review).
Selvakumar P; Pasha MK; Ashakumary L; Dimmock JR; Sharma RK
Int J Mol Med; 2002 Oct; 10(4):493-500. PubMed ID: 12239600
[TBL] [Abstract][Full Text] [Related]
13. TrkA overexpression enhances growth and metastasis of breast cancer cells.
Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.
Kim KY; Baek A; Hwang JE; Choi YA; Jeong J; Lee MS; Cho DH; Lim JS; Kim KI; Yang Y
Cancer Res; 2009 May; 69(9):4018-26. PubMed ID: 19366811
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells.
Han EK; Mcgonigal T; Butler C; Giranda VL; Luo Y
Anticancer Res; 2008; 28(2A):957-63. PubMed ID: 18507042
[TBL] [Abstract][Full Text] [Related]
17. N-myristoyltransferase 2 expression in human colon cancer: cross-talk between the calpain and caspase system.
Selvakumar P; Smith-Windsor E; Bonham K; Sharma RK
FEBS Lett; 2006 Apr; 580(8):2021-6. PubMed ID: 16530191
[TBL] [Abstract][Full Text] [Related]
18. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
Shrivastav A; Sharma AR; Bajaj G; Charavaryamath C; Ezzat W; Spafford P; Gore-Hickman R; Singh B; Copete MA; Sharma RK
Oncol Rep; 2007 Jul; 18(1):93-7. PubMed ID: 17549352
[TBL] [Abstract][Full Text] [Related]
19. Effect of conditioned media from mature human adipocytes on insulin-stimulated Akt/PKB phosphorylation in human skeletal muscle cells: role of BMI and fat cell size.
Skurk T; Alberti-Huber C; Hauner H
Horm Metab Res; 2009 Mar; 41(3):190-6. PubMed ID: 18956303
[TBL] [Abstract][Full Text] [Related]
20. Potential role of N-myristoyltransferase in cancer.
Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
